These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37093559)

  • 1. Nanoparticle-Based MRI-Guided Tumor Microenvironment Heating via the Synergistic Effect of Ferroptosis and Inhibition of TGF-β Signaling.
    Zhou R; Liu Y; Wang Z; Lv J; Liao W; Shen Z; Rong X
    Adv Healthc Mater; 2023 Aug; 12(21):e2300176. PubMed ID: 37093559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cycloacceleration of Reactive Oxygen Species Generation Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for Tumor Ferroptosis Therapy.
    Zhou H; Lu X; Du C; Zhou Z; Feng J; Liang Z; Xu Y; Qiu X; Shen Z
    Small; 2022 Sep; 18(35):e2202705. PubMed ID: 35923138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenton-Reaction-Acceleratable Magnetic Nanoparticles for Ferroptosis Therapy of Orthotopic Brain Tumors.
    Shen Z; Liu T; Li Y; Lau J; Yang Z; Fan W; Zhou Z; Shi C; Ke C; Bregadze VI; Mandal SK; Liu Y; Li Z; Xue T; Zhu G; Munasinghe J; Niu G; Wu A; Chen X
    ACS Nano; 2018 Nov; 12(11):11355-11365. PubMed ID: 30375848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonferrous Ferroptosis Inducer Manganese Molybdate Nanoparticles to Enhance Tumor Immunotherapy.
    Lei H; Li Q; Pei Z; Liu L; Yang N; Cheng L
    Small; 2023 Nov; 19(45):e2303438. PubMed ID: 37420331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction.
    Zhang J; Zuo T; Yang J; Hu Z; Wang Z; Xu R; Ma S; Wei Y; Shen Q
    ACS Appl Mater Interfaces; 2021 Jan; 13(2):2256-2268. PubMed ID: 33423468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
    Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
    Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy.
    Guo S; Xiong W; Zhu J; Feng J; Zhou R; Fan Q; Zhang Q; Li Z; Yang J; Zhou H; Yi P; Feng Y; Yang S; Qiu X; Xu Y; Shen Z
    Biomaterials; 2023 Nov; 302():122300. PubMed ID: 37659110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet Membrane-Camouflaged Magnetic Nanoparticles for Ferroptosis-Enhanced Cancer Immunotherapy.
    Jiang Q; Wang K; Zhang X; Ouyang B; Liu H; Pang Z; Yang W
    Small; 2020 Jun; 16(22):e2001704. PubMed ID: 32338436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supramolecularly Engineered Conjugate of Bacteria and Cell Membrane-Coated Magnetic Nanoparticles for Enhanced Ferroptosis and Immunotherapy of Tumors.
    Xie B; Zhao H; Ding YF; Wang Z; Gao C; Li S; Zhang K; Ip SW; Yu H; Wang R
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304407. PubMed ID: 37850572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy.
    Zhang J; Yang J; Zuo T; Ma S; Xokrat N; Hu Z; Wang Z; Xu R; Wei Y; Shen Q
    Biomaterials; 2021 Jan; 266():120429. PubMed ID: 33035717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking LTB
    Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
    Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors.
    Yi M; Niu M; Wu Y; Ge H; Jiao D; Zhu S; Zhang J; Yan Y; Zhou P; Chu Q; Wu K
    J Hematol Oncol; 2022 Oct; 15(1):142. PubMed ID: 36209176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
    Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
    Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An injectable and active hydrogel induces mutually enhanced mild magnetic hyperthermia and ferroptosis.
    Chen X; Wang H; Shi J; Chen Z; Wang Y; Gu S; Fu Y; Huang J; Ding J; Yu L
    Biomaterials; 2023 Jul; 298():122139. PubMed ID: 37148756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring ROS Responsive Fe
    Zhang L; Qiu M; Wang R; Li S; Liu X; Xu Q; Xiao L; Jiang ZX; Zhou X; Chen S
    Angew Chem Int Ed Engl; 2024 May; 63(22):e202403771. PubMed ID: 38551448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Release of TGF-β Inhibitor Modulates Tumor-Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy.
    Peng H; Shen J; Long X; Zhou X; Zhang J; Xu X; Huang T; Xu H; Sun S; Li C; Lei P; Wu H; Zhao J
    Adv Sci (Weinh); 2022 Apr; 9(10):e2105240. PubMed ID: 35128843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Ferroptosis-Elicited Inflammation Suppresses Hepatocellular Carcinoma Metastasis and Enhances Sorafenib Efficacy.
    Mu M; Huang CX; Qu C; Li PL; Wu XN; Yao W; Shen C; Huang R; Wan CC; Jian ZW; Zheng L; Wu RQ; Lao XM; Kuang DM
    Cancer Res; 2024 Mar; 84(6):841-854. PubMed ID: 38231484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation.
    Chin YC; Yang LX; Hsu FT; Hsu CW; Chang TW; Chen HY; Chen LY; Chia ZC; Hung CH; Su WC; Chiu YC; Huang CC; Liao MY
    J Nanobiotechnology; 2022 Aug; 20(1):373. PubMed ID: 35953837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy.
    Guan Q; Guo R; Huang S; Zhang F; Liu J; Wang Z; Yang X; Shuai X; Cao Z
    J Control Release; 2020 Apr; 320():392-403. PubMed ID: 32004587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.